Joyvie Health raises $1.04M to redesign continence underwear after founder's personal loss. New pouch design cuts stool-to-skin contact by 90% and changes by 70%.
### A Personal Loss Sparks a Mission
Zoe Robson knows what it’s like to watch a loved one suffer. In 2025, her father Fred—a fit 77-year-old—was diagnosed with late-stage pancreatic cancer on Christmas Eve. Eleven weeks later, he was gone.
During those weeks, Fred lost bowel control and had to wear adult nappies. But the design of those nappies made things worse. Stool trapped against his skin caused breakdown, infections, and a loss of dignity. His wife Ruth, his primary caregiver, carried a burden that no one should have to bear.
“My parents didn’t deserve that,” Zoe says. “The product meant to help them was making it worse.”
### A New Approach to an Old Problem
That experience led Zoe to found Joyvie Health, a UK-based startup that’s rethinking continence underwear from the ground up. The company just closed its pre-Seed round, raising $1.04 million (converted from EUR 897k).
The funding comes from an Innovate UK grant, plus investments from HERmesa Angels, SyndicateRoom, Lavender Ventures, and individual angels.
Joyvie’s product is a disposable pouch that contains stool immediately after excretion. This simple change dramatically reduces stool-to-skin contact—by about 90% in early tests. It also speeds up changes by roughly 70%, cutting caregiver burden.
“Products designed for care should never cause harm,” Zoe says. “That’s not a vision statement. It’s the reason this company exists.”
### The Scale of the Problem
Faecal incontinence affects an estimated 656 million people globally. Yet the most common non-invasive solution—nappies and pads—hasn’t changed in decades. These products trap waste against skin, leading to moisture, pathogens, and pH imbalance that cause damage that never fully heals.
Joyvie’s design tackles this head-on. By containing waste in a pouch, it preserves skin integrity, maintains dignity, and reduces the time caregivers spend on changes.
### 2026 HealthTech Funding Surge
Joyvie’s round is part of a bigger trend. In 2026, UK and European HealthTech startups raised over $181 million (converted from EUR 173 million) in related areas. Here’s a snapshot:
- **Semble** raised $36.3 million for its healthcare management platform
- **Evaro** secured $22 million for NHS-licensed health services
- **JAAQ** closed $15.7 million for enterprise partnerships
- **Calibre** emerged with $2.9 million to tackle health guesswork
- **Nul** raised $879k for alcohol-dependence care
- **Recare** (Berlin) raised $38.7 million for AI hospital tools
- **Patronus** raised $11.5 million for senior-friendly smartwatches
- **Tucuvi** raised $17.8 million for voice-AI nursing automation
- **Ditto** (Rotterdam) raised $8 million for patient-friendly medical info
- **ShanX Medtech** secured $25.1 million for antimicrobial-resistance diagnostics
- **MedVasc** raised $2.3 million for anaesthesia catheters
“We believe the market is ripe for innovation,” says Gail Armstrong of Lavender Ventures. “Joyvie’s approach has the potential to deliver significant benefits for individuals, carers, healthcare systems, and the environment.”
### Why This Matters
For Zoe, it’s personal. “My parents were both at their most vulnerable,” she says. “The skin breakdown, the shame, the loss of dignity, the weight on my mum. It wasn’t from lack of care. It’s a design failure.”
Joyvie Health is working to fix that failure—one pouch at a time.